Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

By A. Cohen, B. Davidson, A. Gallus, M. Lassen, M. Prins, W. Tomkowski, A. Turpie, J. Egberts, A. Lensing. British medical journal, 2006

841 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020, background): “Prophylactic anticoagulation reduces the risk of VTE in acutely ill hospitalized medical patients (50-52), and appropriate use of VTE prophylaxis is covered in clinical practice guidelines (49,53,54).”
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. (2021, background): “We identified 1 systematic review(55) that analyzed subgroup data from patients with cancer from 3 RCTs (307 patients with cancer in 5134 study subjects).(56-58) Because of a lack of direct evidence, the guideline panel also included evidence from trials conducted on hospitalized medical patients fr”
Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage (2016, background): “They have also been investigated for the prevention of venous thromboembolism in moderate to high risk populations, including patients undergoing major gynecologic, urologic, or orthopedic surgeries [299–301].”